Adial Pharmaceuticals, Inc (ADIL) Financials
ADIL Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-09-30 | 2.9 million | 528179 |
| 2023-06-30 | 3.8 million | 461752 |
| 2023-03-31 | 3.9 million | 2.5 million |
| 2022-12-31 | 5.7 million | 2.5 million |
ADIL Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-09-30 | -1.4 million | 268374 |
| 2023-06-30 | -1.9 million | 737580 |
| 2023-03-31 | -2.3 million | 459577 |
| 2022-12-31 | -1.8 million | 734144 |
ADIL Net Income
No data available :(
ADIL Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-09-30 | 315880 | - | - |
| 2023-06-30 | 1.2 million | - | - |
| 2023-03-31 | 2.3 million | - | 193796 |
| 2022-12-31 | 4.0 million | - | 207375 |
ADIL Shares Outstanding
ADIL Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-09-30 | - | 207128 | 1.2 million | - |
| 2023-06-30 | - | 429896 | 1.0 million | - |
| 2023-03-31 | - | 676435 | 2.2 million | - |
| 2022-12-31 | - | 1.1 million | 2.1 million | - |
ADIL Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-09-30 | - | 141 |
| 2023-06-30 | - | 141 |
| 2023-03-31 | - | 15841 |
| 2022-12-31 | - | 15546 |
ADIL
Price: $1.76
52 week price:
Earnings Per Share: -8.98 USD
P/E Ratio: -0.14
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 498900
Market Capitalization: 2.0 million